MiNK TherapeuticsINKT
那斯達克 · USD
0
0
(0%)
收盤 01/01 08:00 (UTC+8)
01/01 08:00 (UTC+8)
MiNK TherapeuticsINKT
0
0
(0%)
財務數據
損益表
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2026/Q2 | 2026/Q1 | 2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | |
營業收入淨額 | - | - | - | - | - | - | - | - | - | - |
營業成本 | - | - | - | - | - | - | - | - | - | - |
營業毛利 | - | - | - | - | - | - | - | - | - | - |
營業費用 | 3,217 | 2,882 | 2,705 | 3,183 | 4,052 | 2,701 | - | - | - | 3,829 |
研發費用 | 1,887 | 1,204 | 1,513 | 1,143 | 1,839 | 1,262 | 1,406 | 541 | 1,840 | 2,549 |
推銷及管理費用 | 1,330 | 1,678 | 1,192 | 2,040 | 2,213 | 1,439 | 1,097 | 1,344 | 1,231 | 1,280 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -3,217 | -2,882 | -2,705 | -3,184 | -4,052 | -2,701 | -2,503 | -1,885 | -3,071 | -3,830 |
其他收入及費用 | 89 | 139 | 103 | 296 | -185 | -66 | 40 | 78 | 369 | 17 |
利息費用 | - | - | - | - | - | - | - | - | - | - |
稅前純益 | -3,128 | -2,742 | -2,602 | -2,888 | -4,238 | -2,767 | -2,463 | -1,807 | -2,702 | -3,813 |
所得稅 | - | - | - | - | - | - | - | - | - | - |
稅後純益 | -3,128 | -2,742 | -2,602 | -2,888 | -4,238 | -2,767 | -2,463 | -1,807 | -2,702 | -3,813 |
基本每股稅後盈餘(元) | -0.62 | -0.57 | -0.52 | -0.65 | -1.06 | -0.70 | - | -0.05 | -0.07 | -0.11 |
稀釋每股稅後盈餘(元) | -0.63 | -0.57 | -0.54 | -0.63 | -1.06 | -0.70 | -0.06 | -0.04 | -0.07 | -0.11 |
基本平均股數(千股) | 5023.00 | 4797.00 | 4693.00 | 4443.00 | 3981.00 | 3964.00 | - | 39533.00 | 37142.00 | 34642.00 |
稀釋平均股數(千股) | 5023.00 | 4797.00 | 4693.00 | 4443.00 | 3981.00 | 3964.00 | - | 39533.00 | 37142.00 | 34642.00 |
還原基本每股稅後盈餘(元) | -0.62 | -0.57 | -0.52 | -0.65 | -1.06 | -0.70 | - | -0.46 | -0.73 | -1.10 |
還原稀釋每股稅後盈餘(元) | -0.63 | -0.57 | -0.54 | -0.63 | -1.06 | -0.70 | -0.62 | -0.42 | -0.72 | -1.10 |
還原基本平均股數(千股) | 5,023 | 4,797 | 4,693 | 4,443 | 3,981 | 3,964 | - | 3,953 | 3,714 | 3,464 |
還原稀釋平均股數(千股) | 5,023 | 4,797 | 4,693 | 4,443 | 3,981 | 3,964 | - | 3,953 | 3,714 | 3,464 |
EBITDA(千元) | -3,092 | -2,706 | -2,563 | -2,844 | -4,189 | -2,716 | -2,409 | -1,744 | -2,657 | -3,759 |